CClinicalTrials.gg
CompletedNCT02662491Updated May 9, 2019

Effects of Vitamin D and Calcium Supplementation on Health and Well-being of Vitamin D Deficient UAE Citizens

An interventional study of Vitamin D and calcium and Vitamin D in Vitamin D Deficiency, sponsored by United Arab Emirates University. Completed at 1 site in United Arab Emirates. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-09.

Sponsored by United Arab Emirates University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
545
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The trial plan to determine whether a daily capsule containing vitamin D(3) (2000 IU), calcium (600 mg), both, or a placebo for 6 months in UAE citizens with evidence of vitamin D deficiency will lead to a clinical benefit. The proposed study will also determine the threshold of vitamin D and calcium intake or levels considered optimal for UAE citizen's health

Read the detailed description

The proposed study is a two by two factorial, randomized controlled intervention trial. Following informed written consent of eligible subject's blood and urine samples will be taken for measurements of vitamin D, markers of bone turnover and related biochemical variables. Patients who have evidence of vitamin D deficiency will then be randomly assigned to receive daily vitamin D(3) (2000 IU), calcium (1000 mg), both, or a placebo for 6 months. All subjects will have a calcium and vitamin D rich food and other lifestyle modification advises during the study period. Patients will otherwise be managed according to standard practice. Clinical assessment that includes general and self-rated health, bone density, muscle strength, physical activity and dietary intakes will be performed at baseline, and repeated at 3, 6 and 12 months post-randomisation.

Information on other important variables likely to influence vitamin D status including age, reproductive \& menopausal history, smoking, medications, adiposity, exposure to sunlight, dietary intake including supplements, skin pigmentation, chronic illness and medications will be collected and adjusted for during the analysis

02

Conditions studied

  • Vitamin D Deficiency

Browse trials for

03

In context

Vitamin D Deficiency

772 studies on the registry are indexed under Vitamin D Deficiency; 61 are open to participants now.

This study's enrollment of 545 is above the median of 77 across 564 interventional studies indexed under Vitamin D Deficiency.

Browse Vitamin D Deficiency studies →

Lead sponsor

United Arab Emirates University is the lead sponsor of 24 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. biochemical evidence of vitamin D deficiency

Exclusion criteria

Exclusion Criteria:

  1. renal disease or stones or hypercalcaemia,
  2. Use of calcium and/or vitamin D supplementation, bisphosphonates, steroid medications, hormones or diuretics.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
545 participants (actual)

Study arms

  • Experimental
    vitamin D and calcium

    daily oral vitamin D(3) (2000 IU) and calcium (600 mg) for 6 months

    Dietary Supplement: Vitamin D and calcium

  • Experimental
    Calcium supplement

    daily oral calcium (600 mg) for 6 months

    Dietary Supplement: Calcium

  • Experimental
    vitamin D supplement

    daily oral vitamin D(3) (2000 IU) for 6 months

    Dietary Supplement: Vitamin D

  • Placebo comparator
    Placebo

    daily placebo tablet for 6 months

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementVitamin D and calcium
  • Dietary supplementVitamin D
  • Dietary supplementCalcium
  • Dietary supplementPlacebo
06

What researchers measure

Primary outcomes

  1. Muscle pains

    Muscle pains measured using a questionnaire

    Time frame: 6 months

  2. Muscle strength

    Muscle strength measured using dynamometer

    Time frame: 6 months

  3. Vitamin D level

    vitamin D level measured using liquid chromatography

    Time frame: 6 months

Secondary outcomes

  1. Dietary vitamin D intake

    dietary vitamin D intake assessed by a food frequency questionnaire

    Time frame: 6 months

  2. Dietary calcium intake

    Dietary calcium intake assessed by a food frequency questionnaire

    Time frame: 6 months

07

Study locations

1 site
  • College of Medicine & Health Science
    Al Ain, Abu Dhabi, United Arab Emirates
08

References and documents

Publications

  • Gariballa S, Yasin J, Alessa A. A randomized, double-blind, placebo-controlled trial of vitamin D supplementation with or without calcium in community-dwelling vitamin D deficient subjects. BMC Musculoskelet Disord. 2022 May 3;23(1):415. doi: 10.1186/s12891-022-05364-z. PubMed 35505326 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02662491
Lead sponsor
United Arab Emirates University
Responsible party
Salah Gariballa (Professor, United Arab Emirates University) — Principal investigator
First posted
Jan 25, 2016
Start date
Jan 2017
Primary completion
Mar 2019
Completion
Mar 15, 2019
Last update
May 9, 2019

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion